CVS Health Corp [NYSE: CVS] closed the trading session at $73.09. The company report on January 25, 2024 at 8:00 AM that CVS Health adds two new renewable energy projects with Constellation.
The two investments will reduce the company’s carbon footprint by nearly 114,000 metric tons annually.
CVS Health® (NYSE: CVS) today announced two agreements that total 264,000-megawatt hours with Constellation to purchase zero-emission, renewable energy equivalent to the annual electricity use of nearly 1,000 CVS Health locations in California, Washington, D.C., Delaware, Maryland and New Jersey.
The stocks have a year to date performance of -7.43 percent and weekly performance of 0.12 percent. The stock has been moved at -1.66 percent over the last six months. The stock has performed -9.63 percent around the most recent 30 days and changed 6.34 percent over the most recent 3-months.
If compared to the average trading volume of 9.93M shares, CVS reached to a volume of 10538714 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about CVS Health Corp [CVS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $89.47 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 1.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
HSBC Securities have made an estimate for CVS Health Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 22, 2023.
The Average True Range (ATR) for CVS Health Corp is set at 1.60, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.27. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 12.65. Price to Free Cash Flow for CVS in the course of the last twelve months was 8.32 with Quick ratio for the last quarter at 0.64.
CVS stock trade performance evaluation
CVS Health Corp [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.12. With this latest performance, CVS shares dropped by -9.63% in over the last four-week period, additionally sinking by -1.66% over the last 6 months – not to mention a drop of -16.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 41.26, with the RSI for the last a single of trading hit 38.06, and the three-weeks RSI is set at 44.53 for CVS Health Corp [CVS]. The present Moving Average for the last 50 days of trading for this stock 74.82, while it was recorded at 73.74 for the last single week of trading, and 71.40 for the last 200 days.
CVS Health Corp [CVS]: An insightful look at the core fundamentals
CVS Health Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.64 and a Current Ratio set at 0.86.
Earnings per share (EPS) analysis for CVS Health Corp [CVS] stock
With the latest financial reports released by the company, CVS Health Corp posted 1.99/share EPS, while the average EPS was predicted by analysts to be reported at 1.92/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corp go to 2.35%.
CVS Health Corp [CVS]: Institutional Ownership
The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in CVS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in CVS stock with ownership which is approximately 5.8325%.
